Tooba Bahramfard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tooba Bahramfard has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
A Pourmahmoudi
Centers of Social Factors Affecting Health, Yasuj University of Medical Sciences, Yasuj, Iran
1 shared publicationA Zandi Qashqaei
Department of Veterinary Medicine, Kazerun Branch, Kazerun Azad University, Kazerun, Iran
1 shared publication- Farzad Karimpour
Social Determinants of Health Research Center, Yasuj University of Medical Science, Yasuj, Iran
1 shared publication - Hossein Imani
Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics Tehran University of Medical Sciences Tehran Iran
1 shared publication - Mohammad Amin Ghatee
Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
1 shared publication - Mohammad Pirouze
Students Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran
1 shared publication
Latest Publications
- 5 May 2022
- Published by Springer Nature in European Journal of Nutrition
- Vol. 61 (7) , 3367-3375
Effects of an Iranian traditional fermented food consumption on blood glucose, blood pressure, and lipid profile in type 2 diabetes: a randomized controlled clinical trial
Background Ash-Kardeh is one of the few fermented foods without a dairy base in Iran, which is traditionally prepared from cereals and plants in the presence of microorganisms (mainly lactic acid bacteria). Purpose This study aimed to assess the effects of Ash-Kardeh consumption on blood glucose, lipid profile, and blood pressure in type 2 diabetic patients. Methods Forty-six patients with type 2 diabetes were studied in this randomized controlled clinical trial. Subjects were randomly allocated into intervention (n = 23) and control (n = 23) groups. Individuals of both groups received the usual treatment of diabetic patients, while those in the intervention group, in addition to the usual treatment, received 250 g of Ash-Kardeh daily for 6 weeks. Fasting blood glucose, blood pressure, and lipid profiles were measured before and after the intervention. Results Compared to the control group, Ash-Kardeh consumption led to a significant decrease in fasting blood glucose (P = 0.003), total cholesterol (P = 0.025), triglyceride (P = 0.003), systolic (P < 0.001), and diastolic blood pressure (P = 0.014) in the intervention group. Also, a significant increase in the concentrations of high-density lipoprotein cholesterol (P = 0.048) was observed after Ash-Kardeh consumption. Conclusion It seems that Ash-Kardeh consumption could improve high blood glucose, lipid profile, and hypertension in type 2 diabetic patients but does not affect low-density lipoprotein cholesterol concentrations. This study was registered on 2019-09-15 in the Iranian Registry of Clinical Trials (www.irct.ir) with the code number IRCT20170202032367N3.
- 5 May 2022
- Published by Springer Nature in European Journal of Nutrition
- Vol. 61 (7) , 3367-3375
Effects of an Iranian traditional fermented food consumption on blood glucose, blood pressure, and lipid profile in type 2 diabetes: a randomized controlled clinical trial
Background Ash-Kardeh is one of the few fermented foods without a dairy base in Iran, which is traditionally prepared from cereals and plants in the presence of microorganisms (mainly lactic acid bacteria). Purpose This study aimed to assess the effects of Ash-Kardeh consumption on blood glucose, lipid profile, and blood pressure in type 2 diabetic patients. Methods Forty-six patients with type 2 diabetes were studied in this randomized controlled clinical trial. Subjects were randomly allocated into intervention (n = 23) and control (n = 23) groups. Individuals of both groups received the usual treatment of diabetic patients, while those in the intervention group, in addition to the usual treatment, received 250 g of Ash-Kardeh daily for 6 weeks. Fasting blood glucose, blood pressure, and lipid profiles were measured before and after the intervention. Results Compared to the control group, Ash-Kardeh consumption led to a significant decrease in fasting blood glucose (P = 0.003), total cholesterol (P = 0.025), triglyceride (P = 0.003), systolic (P < 0.001), and diastolic blood pressure (P = 0.014) in the intervention group. Also, a significant increase in the concentrations of high-density lipoprotein cholesterol (P = 0.048) was observed after Ash-Kardeh consumption. Conclusion It seems that Ash-Kardeh consumption could improve high blood glucose, lipid profile, and hypertension in type 2 diabetic patients but does not affect low-density lipoprotein cholesterol concentrations. This study was registered on 2019-09-15 in the Iranian Registry of Clinical Trials (www.irct.ir) with the code number IRCT20170202032367N3.
- Open Access
- 1 March 2022
- Published by CMV Verlag in Armaghane Danesh
- Vol. 27 (2) , 269-281
Evaluation of Mental Health and Well-Being and its Relationship with Weight Gain of Pregnant Mothers During the Outbreak of Covid-19
Background & aim: Considering that pregnant women are one of the health sensitive groups and their mental health and mental well-being is effective on their health, family and society and on the other hand due to the prevalence of COVID-19 pandemic and its effect on psychological dimensions of this study; ...
- 1 March 2022
- Published by CMV Verlag in Armaghane Danesh
- Vol. 27 (2) , 269-281
Open AccessEvaluation of Mental Health and Well-Being and its Relationship with Weight Gain of Pregnant Mothers During the Outbreak of Covid-19
Background & aim: Considering that pregnant women are one of the health sensitive groups and their mental health and mental well-being is effective on their health, family and society and on the other hand due to the prevalence of COVID-19 pandemic and its effect on psychological dimensions of this study; ...